Johnson & Johnson JNJ
NYSE JNJ
$270.24 +2.87 (+1.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Change in Cash (2009 - 2026)

Johnson & Johnson (JNJ) posted Change in Cash of -$1.3 billion for Q2 2026, down 163.97% sequentially from $2.0 billion in Q1 2026, and up 93.64% YoY from -$653.8 million in Q2 2025.

Johnson & Johnson (JNJ) Change in Cash (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Change in Cash for 18 years, with the latest figure at -$1.3 billion in Q2 2026.

  • Quarterly Change in Cash rose 93.64% year-over-year to -$1.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (up 129.28% YoY) and the FY2025 annual result came in at -$4.4 billion, down 295.73% from the prior year.
  • Change in Cash eased to -$1.3 billion in Q2 2026 per JNJ's latest filing, from $2.0 billion in the prior quarter.
  • Over five years, Change in Cash peaked at $14.4 billion in Q1 2025 and troughed at -$19.9 billion in Q2 2025.
  • A 5-year average of -$106.8 million and a median of -$470.5 million in 2024 frame the typical range for Change in Cash.
  • The sharpest annual moves came in 2023 and 2025: Change in Cash jumped 416.55% in 2023, then sank 3244.03% in 2025.
  • Over 5 years, Change in Cash stood at -$4.0 billion in 2022, then soared by 152.96% to $2.1 billion in 2023, then jumped by 93.57% to $4.1 billion in 2024, then slumped by 64.17% to $1.5 billion in 2025, then slumped by 185.66% to -$1.3 billion in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered -$1.3 billion, $2.0 billion, and $1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -1.27 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -2.82 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 1.49 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 739.00 Mn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -4.45 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -727.00 Mn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn -14.32 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 -1.27 Bn
Mar 29, 2026 1.98 Bn
Dec 28, 2025 1.48 Bn
Sep 28, 2025 -346.00 Mn
Jun 29, 2025 -19.90 Bn
Mar 30, 2025 14.37 Bn
Dec 29, 2024 4.13 Bn
Sep 29, 2024 -4.90 Bn
Jun 30, 2024 -595.00 Mn
Mar 31, 2024 3.61 Bn
Dec 31, 2023 2.13 Bn
Oct 1, 2023 -1.46 Bn
Jul 2, 2023 -5.68 Bn
Apr 2, 2023 12.74 Bn
Jan 1, 2023 -3.98 Bn
Apr 3, 2022 -4.02 Bn
Oct 3, 2021 3.27 Bn
Jul 4, 2021 1.66 Bn
Apr 4, 2021 -1.31 Bn
Jan 3, 2021 -4.98 Bn